Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Lifestyle Natural Medicines

PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine

(marketscreener.com) PharmaDrug Inc. , a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines, and previously approved drugs, is pleased to announce that it has initia

By: Marketscreener.com

Apr 05 2024
5
283 Views

PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine

Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, develo… [+8090 chars]

Related

Meeting on relief, disaster management held in Margherita

Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet Syndrome

Medical benefits of psychedelic mushrooms identified by Israeli researchers

Researcher creates algorithm to aid in discovery of new medicines

Singapore: A Tale of Two IEAs

Global Astaxanthin Market Size is projected to reach USD 7,536.19 million by 2031, growing at a CAGR of 16.78%: Straits Research

Core One Labs (OTCMKTS:CLABF) Stock Price Down 1.3%

The 5 best medicated dog shampoos in 2024

BLACK SKULL LAUNCHES AT A FAIR IN CALIFORNIA A POST-WORKOUT WITH EXCLUSIVE SALE ON AMAZON

Magic and Medicinal: On the Pharmacological Potential of Mushrooms

Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia

BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rare natural history study of patients living with inherited retinal diseases

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

Meeting on relief, disaster management held in Margherita